Development of orthotopic pancreatic tumor mouse models

Methods in Molecular Biology

Volumn 980, Issue , 2013, Pages 215-223

  Qiu, Wanglong ^a   Su, Gloria H ^a  

^a NONE

Author keywords

Mouse model; Orthotopic; Pancreatic cancer; Xenograft

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CANCER MODEL; CANCER TRANSPLANTATION; CARCINOGENESIS; FEMALE; GENETICALLY ENGINEERED MOUSE STRAIN; MOUSE; NONHUMAN; PANCREAS CANCER; PRIORITY JOURNAL; ANIMAL; DISEASE MODEL; HUMAN; METHODOLOGY; PANCREAS TUMOR; PATHOLOGY; TUMOR CELL LINE; XENOGRAFT;

ANIMALS; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; HUMANS; MICE; NEOPLASM TRANSPLANTATION; PANCREATIC NEOPLASMS; TRANSPLANTATION, HETEROLOGOUS;

MLCS; MLOWN;

EID: 84879568732     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-62703-287-2_11     Document Type: Article

References (16)

1. Kern SE (2000) Molecular genetic alterations in ductal pancreatic adenocarcinomas. Med Clin North Am 84(3):691-695, xi
2. Hingorani SR et al (2003) Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer Cell 4(6): 437-450
3. Hingorani SR et al (2005) Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice. Cancer Cell 7(5):469-483, see comment
4. Fu X, Guadagni F, Hoffman RM (1992) A metastatic nude-mouse model of human pancreatic cancer constructed orthotopically with histologically intact patient specimens. Proc Natl Acad Sci USA 89(12):5645-5649
5. Rubio-Viqueira B et al (2006) An in vivo platform for translational drug development in pancreatic cancer. Clin Cancer Res 12(15): 4652-4661
6. Killion JJ, Radinsky R, Fidler IJ (1998) Orthotopic models are necessary to predict therapy of transplantable tumors in mice. Cancer Metastasis Rev 17(3):279-284
7. Huynh AS et al (2011) Development of an orthotopic human pancreatic cancer xenograft model using ultrasound guided injection of cells. PLoS One 6(5):e20330
8. Qiu W et al (2011) Disruption of p16 and activation of Kras in pancreas increases ductal adenocarcinoma formation and metastasis in vivo. Oncotarget 2(11):862-873
9. Tseng WW et al (2010) Development of an orthotopic model of invasive pancreatic cancer in an immunocompetent murine host. Clin Cancer Res 16(14):3684-3695
10. Gray MJ et al (2005) Neuropilin-1 suppresses tumorigenic properties in a human pancreatic adenocarcinoma cell line lacking neuropilin-1 coreceptors. Cancer Res 65(9): 3664-3670
11. Ito M et al (2002) NOD/SCID/gamma(c) (null) mouse: an excellent recipient mouse model for engraftment of human cells. Blood 100(9):3175-3182
12. Quintana E et al (2008) Ef ficient tumour formation by single human melanoma cells. Nature 456(7222):593-598
13. Trevino JG et al (2006) Inhibition of SRC expression and activity inhibits tumor progression and metastasis of human pancreatic adenocarcinoma cells in an orthotopic nude mouse model. Am J Pathol 168(3):962-972
14. Partecke IL et al (2011) In vivo imaging of pancreatic tumours and liver metastases using 7 Tesla MRI in a murine orthotopic pancreatic cancer model and a liver metastases model. BMC Cancer 11:40
15. McNally LR et al (2010) KISS1 over-expression suppresses metastasis of pancreatic adenocarcinoma in a xenograft mouse model. Clin Exp Metastasis 27(8):591-600
16. Kunnumakkara AB et al (2012) Zy flamend suppresses growth and sensitizes human pancreatic tumors to gemcitabine in an orthotopic mouse model through modulation of multiple targets. Int J Cancer 131(3): E292-E303